GLENMARK LIFE SCIENCES LIMITED 4TH

GLENMARK LIFE SCIENCES LIMITED is a factory/manufacturer.

Company Introduction:

Glenmark Life Sciences Limited is an Indian pharmaceutical company primarily engaged in the development, manufacturing, and marketing of Active Pharmaceutical Ingredients (APIs). The company provides high-quality APIs across various therapeutic areas, serving both generic and innovative pharmaceutical companies globally.

It also offers Contract Development and Manufacturing Organization (CDMO) services, leveraging its robust research and development capabilities, state-of-the-art manufacturing facilities, and strong regulatory compliance. Glenmark Life Sciences was demerged from Glenmark Pharmaceuticals Ltd. and has established itself as a significant player in the global API market, known for its focus on quality, innovation, and customer satisfaction.

GLENMARK LIFE SCIENCES LIMITED manufactures or sells Active Pharmaceutical Ingredients (APIs) and offers Contract Development and Manufacturing Organization (CDMO) services.

Their product portfolio primarily consists of APIs across various therapeutic areas, including:

Cardiovascular System: Such as Telmisartan, Valsartan, Irbesartan, Olmesartan Medoxomil, Cilnidipine.

Central Nervous System: Such as Ropinirole, Pramipexole.

Pain Management and Anti-inflammatory: Such as Etoricoxib, Celecoxib, Diclofenac Sodium.

Anti-diabetic: Such as Sitagliptin, Linagliptin, Vildagliptin.

Anti-infectives: Such as Linezolid, Posaconazole, Itraconazole.

Oncology: Such as Aprepitant, Pomalidomide, Lenalidomide.

Anti-allergics: Such as Fexofenadine.

Gastrointestinal: Such as Pantoprazole, Rabeprazole, Esomeprazole.

Other specialized APIs include Adapalene, Fingolimod, Tofacitinib, Rivaroxaban, Apixaban.

In addition to API manufacturing, the company provides CDMO services, focusing on the development and manufacturing of advanced intermediates and APIs for innovator pharmaceutical companies.